{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:55:03Z","timestamp":1791971703066,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":127,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","award":["WP2587148"],"award-info":[{"award-number":["WP2587148"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.aicoj.2026.100082","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:23:21Z","timestamp":1778819001000},"page":"100082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failure"],"prefix":"10.1016","volume":"16","author":[{"given":"Emily","family":"Behrens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Jarczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Martens-Lobenhoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie M.","family":"Bode-B\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian G.","family":"Wicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Grensemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.aicoj.2026.100082_bib0005","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fernandez","year":"2018","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.aicoj.2026.100082_bib0010","first-page":"649","article-title":"Acute-on-chronic liver failure: a diagnostic and therapeutic challenge for intensive care","volume":"113","author":"Hubener","year":"2018","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"9","key":"10.1016\/j.aicoj.2026.100082_bib0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/MEG.0000000000000927","article-title":"Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis","volume":"29","author":"Gravito-Soares","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"37","key":"10.1016\/j.aicoj.2026.100082_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008057","article-title":"Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure","volume":"96","author":"Cai","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.aicoj.2026.100082_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.aicoj.2026.100082_bib0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4254\/wjh.v16.i3.379","article-title":"Comparison of fungal vs bacterial infections in the medical intensive liver unit: cause or corollary for high mortality?","volume":"16","author":"Khan","year":"2024","journal-title":"World J Hepatol"},{"issue":"8","key":"10.1016\/j.aicoj.2026.100082_bib0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.aicoj.2026.100082_bib0040","unstructured":"Cresemba Medicine Overview, Annex I: Summary of Product Characteristics [https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cresemba-epar-product-information_en.pdf]."},{"issue":"1","key":"10.1016\/j.aicoj.2026.100082_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13613-020-00666-8","article-title":"Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study","volume":"10","author":"Grensemann","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.aicoj.2026.100082_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13613-023-01184-z","article-title":"Acute-on-chronic liver failure alters linezolid pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study","volume":"13","author":"Tikiso","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.aicoj.2026.100082_bib0055","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.aicoj.2026.100082_bib0060","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.aicoj.2026.100082_bib0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/liv.13389","article-title":"Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications","volume":"37","author":"Staufer","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.aicoj.2026.100082_bib0070","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00134-019-05886-6","article-title":"The persistent potential of extracorporeal therapies in liver failure","volume":"46","author":"Fuhrmann","year":"2020","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.aicoj.2026.100082_bib0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure","volume":"79","year":"2023","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.aicoj.2026.100082_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9102087","article-title":"Voriconazole pharmacokinetics are not altered in critically ill patients with acute-on-chronic liver failure and continuous renal replacement therapy: an observational study","volume":"9","author":"Grensemann","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.aicoj.2026.100082_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124590","article-title":"Quantification of isavuconazole from dried blood spots: applicability in therapeutic drug monitoring","volume":"1258","author":"Martens-Lobenhoffer","year":"2025","journal-title":"J Chromatogr B"},{"issue":"3","key":"10.1016\/j.aicoj.2026.100082_bib0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit\u2014A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"issue":"6","key":"10.1016\/j.aicoj.2026.100082_bib0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11095-020-02832-w","article-title":"An Integrated Dialysis Pharmacometric (IDP) model to evaluate the pharmacokinetics in patients undergoing renal replacement therapy","volume":"37","author":"Broeker","year":"2020","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.aicoj.2026.100082_bib0100","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.04907-14","article-title":"Pharmacodynamics of isavuconazole in an aspergillus fumigatus mouse infection model","volume":"59","author":"Seyedmousavi","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.aicoj.2026.100082_bib0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jac\/dkx354","article-title":"Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs","volume":"73","author":"Buil","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.aicoj.2026.100082_bib0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cpdd.376","article-title":"Desai A: Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of (14) C-Labeled Isavuconazonium Sulfate in Healthy Male Volunteers","volume":"7","author":"Townsend","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"1","key":"10.1016\/j.aicoj.2026.100082_bib0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/cpdd.282","article-title":"Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg\/Ritonavir 100 mg in Healthy Subjects","volume":"6","author":"Yamazaki","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"12","key":"10.1016\/j.aicoj.2026.100082_bib0120","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01034-17","article-title":"Exposure-response relationships for isavuconazole in patients with invasive aspergillosis and other filamentous fungi","volume":"61","author":"Desai","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.aicoj.2026.100082_bib0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/antibiotics10050487","article-title":"Therapeutic drug monitoring of isavuconazole: serum concentration variability and success rates for reaching target in comparison with voriconazole","volume":"10","author":"Risum","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.aicoj.2026.100082_bib0130","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000000952","article-title":"Antifungal drugs TDM: trends and update","volume":"44","author":"Kably","year":"2022","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.aicoj.2026.100082_bib0135","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.2147\/IDR.S434622","article-title":"Population pharmacokinetics of isavuconazole in adult: a systematic review","volume":"16","author":"Chen","year":"2023","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.aicoj.2026.100082_bib0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01085-19","article-title":"Pharmacokinetics and dialytic clearance of isavuconazole during in vitro and in vivo continuous renal replacement therapy","volume":"63","author":"Biagi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.aicoj.2026.100082_bib0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcrc.2021.12.008","article-title":"Impact of hypoalbuminemia on mortality in critically ill patients requiring continuous renal replacement therapy","volume":"68","author":"Thongprayoon","year":"2022","journal-title":"J Crit Care"},{"key":"10.1016\/j.aicoj.2026.100082_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1546465","article-title":"Effect of hypoalbuminemia on drug pharmacokinetics","volume":"16","author":"Idasiak-Piechocka","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.aicoj.2026.100082_bib0155","doi-asserted-by":"crossref","first-page":"e02032","DOI":"10.1128\/AAC.02032-20","article-title":"A physiologically based pharmacokinetic analysis to predict the pharmacokinetics of intravenous isavuconazole in patients with or without hepatic impairment","volume":"65","author":"Huang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.aicoj.2026.100082_bib0160","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.00319-09","article-title":"Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557","volume":"53","author":"Schmitt-Hoffmann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.aicoj.2026.100082_bib0165","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00228-017-2213-7","article-title":"Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics","volume":"73","author":"Townsend","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.aicoj.2026.100082_bib0170","unstructured":"Antimicrobial wild type distributions of microorganisms [https:\/\/mic.eucast.org\/search\/?search%5Bmethod%5D=mic&search%5Bantibiotic%5D=111&search%5Bspecies%5D=-1&search%5Bdisk_content%5D=-1&search%5Blimit%5D=50]."},{"issue":"9","key":"10.1016\/j.aicoj.2026.100082_bib0175","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1128\/AAC.02819-15","article-title":"Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi","volume":"60","author":"Desai","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.aicoj.2026.100082_bib0180","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/jac\/dkz188","article-title":"Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy","volume":"74","author":"Furfaro","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.aicoj.2026.100082_bib0185","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/17425255.2025.2545920","article-title":"Suboptimal concentrations of isavuconazole in critically ill patients treated for mold infections: a population pharmacokinetic analysis","volume":"21","author":"Rabault","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"10.1016\/j.aicoj.2026.100082_bib0190","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/AAC.04569-14","article-title":"Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study","volume":"59","author":"Cornely","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.aicoj.2026.100082_bib0195","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/cpdd.1079","article-title":"Pharmacokinetics, safety, and tolerability of single and multiple doses of isavuconazonium sulfate in healthy adult Japanese subjects","volume":"11","author":"Shirae","year":"2022","journal-title":"Clin Pharmacol Drug Dev"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582026001172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582026001172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:34:54Z","timestamp":1791970494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582026001172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"alternative-id":["S2110582026001172"],"URL":"https:\/\/doi.org\/10.1016\/j.aicoj.2026.100082","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failure","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aicoj.2026.100082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise (French Intensive Care Society).","name":"copyright","label":"Copyright"}],"article-number":"100082"}}